Retraction
Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists
Paper Information
Record ID:
37353
Publication Date:
April 05, 2019
Retraction Date:
May 17, 2022
(3.5 years years ago)
Subjects:
Institutions:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Chemical Society (ACS)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reason:
Nature of Retraction:
Retraction
Retraction Notice:
10.1021/acsmedchemlett.2c00197Citations (19)
19
Total Citations10
Post-Retraction(52.6%)
9
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
6
Within 1 year
3
After 2+ years
1134
Days since retraction (latest)
Orally Bioavailable Dopamine D1/D5 Receptor-Biased Agonists to Study the Role of β-Arrestin in Treatment-Related Dyskinesia in Parkinson’s Disease
Rosa Marı́a Rodrı́guez Sarmiento, Susanne Berchtold, Nenad Manevski et al. (10 authors)
Journal of Medicinal Chemistry
Published: Jun 2025
1134 days after retraction
Functionally Selective Dopamine D1 Receptor Endocytosis and Signaling by Catechol and Noncatechol Agonists
Ashley N. Nilson, Daniel E. Felsing, Pingyuan Wang et al. (6 authors)
Biochemistry
Open Access
Published: Mar 2025
1038 days after retraction
Exploring the Reactivity of α-Halo Ethers with 2,3′-Anhydrothymidine and 2,2′-Anhydrouridine Derivatives
Monique Mathé-Allainmat, V. Baran, Quentin Foucart et al. (5 authors)
Synthesis
Published: Mar 2025
1022 days after retraction
Functionally selective dopamine D1 receptor endocytosis and signaling by catechol and non-catechol agonists
Ashley N. Nilson, Daniel E. Felsing, Pingyuan Wang et al. (6 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Apr 2024
1 citation
1 citation
701 days after retraction
Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease
Mechelle M. Lewis, Lauren J. Van Scoy, Sol De Jesus et al. (14 authors)
Biomolecules
Open Access
Published: May 2023
10 citations
10 citations
360 days after retraction
Computational insights into ligand–induced G protein and β-arrestin signaling of the dopamine D1 receptor
Haoxi Li, Nikhil M. Urs, Nicole A. Horenstein
Journal of Computer-Aided Molecular Design
Published: Apr 2023
8 citations
8 citations
333 days after retraction
A multi-stimuli responsive donor-acceptor Stenhouse adducts: Synthesis, aggregation-induced emission, multi-switch behavior and information storage
Chen Wang, Qing Yan, Sheng Wang et al. (4 authors)
Dyes and Pigments
Published: Sep 2022
3 citations
3 citations
134 days after retraction
Dopamine Receptors: Neurotherapeutic Targets for Substance Use Disorders
Ashley N. Nilson, Daniel E. Felsing, John Allen
Unknown Journal
Published: Sep 2022
2 citations
2 citations
122 days after retraction
Ligand recognition and biased agonism of the D1 dopamine receptor
Xiao Teng, Sijia Chen, Yingying Nie et al. (7 authors)
Nature Communications
Open Access
Published: Jun 2022
38 citations
38 citations
22 days after retraction
Structure–Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor Agonists
Haoxi Li, Rosa Mirabel, Joseph Zimmerman et al. (7 authors)
ACS Chemical Neuroscience
Published: Jun 2022
3 citations
3 citations
20 days after retraction
Dopamine D<sub>1</sub>agonist effects in late-stage Parkinson’s disease
Mechelle M. Lewis, Lauren J. Van Scoy, Richard B. Mailman et al. (11 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: May 2022
3 citations
3 citations
14 days before retraction
The Signaling and Pharmacology of the Dopamine D1 Receptor
Jace Jones-Tabah, Hanan Mohammad, Emma G. Paulus et al. (5 authors)
Frontiers in Cellular Neuroscience
Open Access
Published: Jan 2022
53 citations
53 citations
120 days before retraction
Structure-Functional-Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward Discovery of Biased D1 Agonists
Haoxi Li, Rosa Mirabel, Joseph Zimmerman et al. (7 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Oct 2021
228 days before retraction
Computationally-guided tuning of ligand sensitivity in a GPCR-based sensor
Dániel Kéri, Reto B. Cola, Zacharoula Kagiampaki et al. (5 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Sep 2021
3 citations
3 citations
235 days before retraction
Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist
Bingfa Sun, Dan Feng, Matthew Ling-Hon Chu et al. (13 authors)
Nature Communications
Open Access
Published: Jun 2021
50 citations
50 citations
348 days before retraction
Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes
Peng Xiao, Wei Yan, Lu Gou et al. (29 authors)
Cell
Open Access
Published: Feb 2021
130 citations
130 citations
470 days before retraction
Recent advances in dopaminergic strategies for the treatment of Parkinson’s disease
Qi Mao, Wangzhi Qin, Ao Zhang et al. (4 authors)
Acta Pharmacologica Sinica
Open Access
Published: Feb 2020
78 citations
78 citations
809 days before retraction
Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics
Daniel E. Felsing, Manish K. Jain, John Allen
Current Topics in Medicinal Chemistry
Published: Sep 2019
28 citations
28 citations
979 days before retraction
Designing Functionally Selective Noncatechol Dopamine D<sub>1</sub> Receptor Agonists with Potent In Vivo Antiparkinsonian Activity
Michael L. Martini, Caroline Ray, Xufen Yu et al. (10 authors)
ACS Chemical Neuroscience
Open Access
Published: Aug 2019
29 citations
29 citations
1015 days before retraction
Quick Stats
Total Citations:
19
Years Since Retraction:
3.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025